Sign In
NASDAQ:AMED
Amedisys Inc Stock Earnings Reports
$92.64
+0.0700 (+0.0756%)
At Close: Mar 17, 2025
Amedisys Earnings Calls
Q4 2024
Missed
$0.96 (-8.57%)
| Release date | Feb 26, 2025 |
| EPS estimate | $1.05 |
| EPS actual | $0.96 |
| EPS Surprise | -8.57% |
| Revenue estimate | 602.384M |
| Revenue actual | 598.052M |
| Revenue Surprise | -0.719% |
Q3 2024
Missed
$1.00 (-14.53%)
| Release date | Nov 06, 2024 |
| EPS estimate | $1.17 |
| EPS actual | $1.00 |
| EPS Surprise | -14.53% |
| Revenue estimate | 596.432M |
| Revenue actual | 587.671M |
| Revenue Surprise | -1.47% |
Q2 2024
Beat
$1.32 (8.20%)
| Release date | Jul 24, 2024 |
| EPS estimate | $1.22 |
| EPS actual | $1.32 |
| EPS Surprise | 8.20% |
| Revenue estimate | 578.82M |
| Revenue actual | 591.187M |
| Revenue Surprise | 2.14% |
Q1 2024
Beat
$1.03 (1.98%)
| Release date | Apr 24, 2024 |
| EPS estimate | $1.01 |
| EPS actual | $1.03 |
| EPS Surprise | 1.98% |
| Revenue estimate | 565.38M |
| Revenue actual | 571.414M |
| Revenue Surprise | 1.07% |
Last 4 Quarters for Amedisys
Below you can see how AMED performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Q1 2024
Beat
| Release date | Apr 24, 2024 |
| Fiscal end date | Mar 31, 2024 |
| Price on release | $91.05 |
| EPS estimate | $1.01 |
| EPS actual | $1.03 |
| EPS surprise | 1.98% |
| Date | Price |
|---|---|
| Apr 18, 2024 | $90.78 |
| Apr 19, 2024 | $90.40 |
| Apr 22, 2024 | $91.24 |
| Apr 23, 2024 | $91.16 |
| Apr 24, 2024 | $91.05 |
| Apr 25, 2024 | $91.16 |
| Apr 26, 2024 | $91.79 |
| Apr 29, 2024 | $91.84 |
| Apr 30, 2024 | $92.05 |
| 4 days before | 0.297% |
| 4 days after | 1.10% |
| On release day | 0.121% |
| Change in period | 1.40% |
Q2 2024
Beat
| Release date | Jul 24, 2024 |
| Fiscal end date | Jun 30, 2024 |
| Price on release | $97.58 |
| EPS estimate | $1.22 |
| EPS actual | $1.32 |
| EPS surprise | 8.20% |
| Date | Price |
|---|---|
| Jul 18, 2024 | $97.73 |
| Jul 19, 2024 | $97.60 |
| Jul 22, 2024 | $97.45 |
| Jul 23, 2024 | $97.75 |
| Jul 24, 2024 | $97.58 |
| Jul 25, 2024 | $97.75 |
| Jul 26, 2024 | $98.25 |
| Jul 29, 2024 | $98.11 |
| Jul 30, 2024 | $98.05 |
| 4 days before | -0.153% |
| 4 days after | 0.482% |
| On release day | 0.174% |
| Change in period | 0.327% |
Q3 2024
Missed
| Release date | Nov 06, 2024 |
| Fiscal end date | Sep 30, 2024 |
| Price on release | $97.71 |
| EPS estimate | $1.17 |
| EPS actual | $1.00 |
| EPS surprise | -14.53% |
| Date | Price |
|---|---|
| Oct 31, 2024 | $94.60 |
| Nov 01, 2024 | $95.49 |
| Nov 04, 2024 | $95.39 |
| Nov 05, 2024 | $95.96 |
| Nov 06, 2024 | $97.71 |
| Nov 07, 2024 | $96.80 |
| Nov 08, 2024 | $96.71 |
| Nov 11, 2024 | $92.68 |
| Nov 12, 2024 | $91.00 |
| 4 days before | 3.29% |
| 4 days after | -6.87% |
| On release day | -0.93% |
| Change in period | -3.81% |
Q4 2024
Missed
| Release date | Feb 26, 2025 |
| Fiscal end date | Dec 31, 2024 |
| Price on release | $91.57 |
| EPS estimate | $1.05 |
| EPS actual | $0.96 |
| EPS surprise | -8.57% |
| Date | Price |
|---|---|
| Feb 20, 2025 | $91.09 |
| Feb 21, 2025 | $90.44 |
| Feb 24, 2025 | $91.54 |
| Feb 25, 2025 | $91.54 |
| Feb 26, 2025 | $91.57 |
| Feb 27, 2025 | $91.68 |
| Feb 28, 2025 | $92.00 |
| Mar 03, 2025 | $92.00 |
| Mar 04, 2025 | $92.10 |
| 4 days before | 0.527% |
| 4 days after | 0.579% |
| On release day | 0.120% |
| Change in period | 1.11% |
Amedisys Earnings History
Earnings Calendar
FAQ
When is the earnings report for AMED?
Amedisys Inc (AMED) has scheduled its earnings report for Apr 23, 2025 before the markets open.
What is the AMED price-to-earnings (P/E) ratio?
AMED P/E ratio as of Mar 17, 2025 (TTM) is 44.72.
What is the AMED EPS forecast?
The forecasted EPS (Earnings Per Share) for Amedisys Inc (AMED) for the first fiscal quarter 2025 is $1.15.
What are Amedisys Inc's retained earnings?
On its balance sheet, Amedisys Inc reported retained earnings of $598.05 million for the latest quarter ending Dec 31, 2024.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
